Exelixis financials
$58.65+0.48%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Jan 2 | FY24 Jan 3 | FY23 Dec 29 | FY22 Dec 30 | FY21 Dec 31 | FY20 Jan 1 | FY19 Jan 3 | FY18 Dec 28 | FY17 Dec 29 | FY16 Dec 30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B | $1.43B | $987.5M | $967.8M | $853.8M | $452.5M | $191.5M |
| Gross profit | $2.24B | $2.09B | $1.76B | $1.55B | $1.38B | $951.3M | $934.7M | $827.5M | $437.4M | $184.9M |
| Gross margin | 96.4% | 96.5% | 96.0% | 96.4% | 96.3% | 96.3% | 96.6% | 96.9% | 96.7% | 96.6% |
| Operating income | $872.2M | $604.6M | $170.9M | $201.5M | $286.7M | $110.1M | $369.5M | $438.9M | $165.9M | -$28.1M |
| Net income | $782.6M | $521.3M | $207.8M | $182.3M | $231.1M | $111.8M | $321.0M | $690.1M | $154.2M | -$70.2M |
| Net margin | 33.7% | 24.0% | 11.4% | 11.3% | 16.1% | 11.3% | 33.2% | 80.8% | 34.1% | −36.7% |
| Diluted EPS | $2.78 | $1.76 | $0.65 | $0.56 | $0.72 | $0.35 | $1.02 | $2.21 | $0.49 | $-0.28 |
| EBITDA | $921.8M | $718.8M | $196.6M | $222.4M | $300.3M | $119.2M | $377.8M | $443.8M | $167.1M | -$26.2M |
| Operating cash flow | $884.3M | $700.0M | $333.3M | $362.6M | $400.8M | $209.0M | $527.0M | $415.7M | $165.6M | $210.4M |
| Free cash flow | $875.8M | $671.5M | $292.9M | $224.2M | $336.6M | $178.6M | $514.1M | $382.4M | $144.5M | $208.7M |
| Diluted shares | 281.9M | 296.1M | 321.5M | 324.6M | 322.4M | 318.0M | 315.0M | 312.8M | 312.0M | 250.5M |
Balance sheet
| Period end | Jan 2 | Jan 3 | Dec 29 | Dec 30 | Dec 31 | Jan 1 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $482.5M | $217.4M | $263.0M | $501.2M | $647.2M | $319.2M |
| Short-term investments | $576.6M | $893.9M | $732.3M | $807.3M | $819.9M | $887.3M |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $2.84B | $2.95B | $2.94B | $3.07B | $2.62B | $2.14B |
| Total liabilities | $683.1M | $703.5M | $678.4M | $583.1M | $405.6M | $258.2M |
| Shareholders' equity | $2.16B | $2.24B | $2.26B | $2.49B | $2.21B | $1.88B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology